Cubist Systematic Strategies, LLC Inmune Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$10.53 - $14.01 $50,354 - $66,995	4,782 New	4,782 $56,000
Q4 2021 Feb 14, 2022	SELL	$9.97 - $20.38 $199,290 - $407,375	-19,989 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.13 - $27.85 $282,444 - $556,693	19,989 New	19,989 $388,000
Q4 2020 Feb 16, 2021	SELL	$7.51 - $17.22 $7,510 - $17,220	-1,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.92 - $15.75 $4,920 - $15,750	1,000 New	1,000 $10,000

5.92M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $79.3M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.